VRE vs. WELL, AGF.B, SVC, GS, ARR, OSI, STEP, REG, SBC, and DC.A
Should you be buying Vanguard FTSE Canadian Capped REIT Index ETF stock or one of its competitors? The main competitors of Vanguard FTSE Canadian Capped REIT Index ETF include WELL Health Technologies (WELL), AGF Management (AGF.B), Sandvine (SVC), Gluskin Sheff + Associates (GS), Altius Renewable Royalties (ARR), Osino Resources (OSI), STEP Energy Services (STEP), Regulus Resources (REG), Brompton Split Banc (SBC), and Dundee (DC.A). These companies are all part of the "trading" industry.
Vanguard FTSE Canadian Capped REIT Index ETF vs.
Vanguard FTSE Canadian Capped REIT Index ETF (TSE:VRE) and WELL Health Technologies (TSE:WELL) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.
WELL Health Technologies has higher revenue and earnings than Vanguard FTSE Canadian Capped REIT Index ETF.
WELL Health Technologies received 36 more outperform votes than Vanguard FTSE Canadian Capped REIT Index ETF when rated by MarketBeat users. Likewise, 59.21% of users gave WELL Health Technologies an outperform vote while only 45.00% of users gave Vanguard FTSE Canadian Capped REIT Index ETF an outperform vote.
In the previous week, Vanguard FTSE Canadian Capped REIT Index ETF had 2 more articles in the media than WELL Health Technologies. MarketBeat recorded 2 mentions for Vanguard FTSE Canadian Capped REIT Index ETF and 0 mentions for WELL Health Technologies. WELL Health Technologies' average media sentiment score of 0.99 beat Vanguard FTSE Canadian Capped REIT Index ETF's score of 0.37 indicating that WELL Health Technologies is being referred to more favorably in the news media.
WELL Health Technologies has a consensus target price of C$8.08, suggesting a potential upside of 103.91%. Given WELL Health Technologies' stronger consensus rating and higher possible upside, analysts clearly believe WELL Health Technologies is more favorable than Vanguard FTSE Canadian Capped REIT Index ETF.
WELL Health Technologies has a net margin of 7.67% compared to Vanguard FTSE Canadian Capped REIT Index ETF's net margin of 0.00%. WELL Health Technologies' return on equity of 8.74% beat Vanguard FTSE Canadian Capped REIT Index ETF's return on equity.
5.6% of WELL Health Technologies shares are held by institutional investors. 6.8% of WELL Health Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
WELL Health Technologies beats Vanguard FTSE Canadian Capped REIT Index ETF on 12 of the 13 factors compared between the two stocks.
Get Vanguard FTSE Canadian Capped REIT Index ETF News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vanguard FTSE Canadian Capped REIT Index ETF Competitors List
Related Companies and Tools
This page (TSE:VRE) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy VRE Stock Free VRE Stock Alerts